Azithromycin ophthalmic solution, 1%

DRUG6 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

BlepharitisContact Lens Dry EyeDry Eye DiseasePosterior Blepharoconjunctivitis

Phase 2

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period

CompletedNCT00892970

Merck Sharp & Dohme LLCBlepharitis

Start: 2009-04-30End: 2010-01-31Updated: 2011-09-26

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)

CompletedNCT00894530

Merck Sharp & Dohme LLCBlepharitis

Start: 2009-05-31End: 2009-12-31Updated: 2013-11-21

A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)

TerminatedNCT01220258

Merck Sharp & Dohme LLCPosterior Blepharoconjunctivitis

Start: 2010-11-30End: 2011-08-31Updated: 2013-12-16

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Vehicle in Subjects With Blepharitis (P08636)

TerminatedNCT01269658

Merck Sharp & Dohme LLCBlepharitis

Start: 2010-12-31End: 2011-06-30Updated: 2013-11-21

Phase 4

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease

CompletedNCT01014078

Merck Sharp & Dohme LLCDry Eye Disease

Start: 2009-10-31End: 2010-03-31Updated: 2011-09-26

A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Rewetting Drops in Subjects With History and Current Complaint of Contact Lens-Related Dry Eye (CLDE)

CompletedNCT01105624

Merck Sharp & Dohme LLCContact Lens Dry Eye

Start: 2010-03-31End: 2010-11-30Updated: 2011-09-26